Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-16-000038

CFO, Sec., Treas acquired 122,325 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ward Carter Julian · CFO, Sec., Treas

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-02-16 Grant or award : show line 1 in the form +122,325 $0.25 $29,994 1,085,618 D
Loading xslF345X03/primary_doc.xml…